Sakai Chemical Industry Co., Ltd. Stock

Equities

4078

JP3312800000

Commodity Chemicals

Market Closed - Japan Exchange 02:00:00 2024-04-25 am EDT 5-day change 1st Jan Change
2,024 JPY +0.55% Intraday chart for Sakai Chemical Industry Co., Ltd. -0.15% +7.89%
Sales 2024 * 84B 540M Sales 2025 * 88B 566M Capitalization 32.81B 211M
Net income 2024 * -7B -44.99M Net income 2025 * 2.1B 13.5M EV / Sales 2024 * 0.39 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 0.37 x
P/E ratio 2024 *
-4.69 x
P/E ratio 2025 *
15.6 x
Employees 2,013
Yield 2024 *
3.46%
Yield 2025 *
3.71%
Free-Float 83.99%
More Fundamentals * Assessed data
Dynamic Chart
Sakai Chemical Industry Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending March 31, 2024 CI
Sakai Chemical Industry Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024 CI
Sakai Chemical Industry Develops Environmental Friendly Catalyst MT
Sakai Chemical Industry Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024 CI
Sakai Chemical Industry Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending March 31, 2024 CI
Sakai Chemical Industry Co., Ltd. Announces Dividend for the Second Quarter Ended September 30, 2023, Payable on December 01, 2023 CI
Sakai Chemical Industry Co., Ltd. Provides Consolidated Earnings Guidance for the Six Months Ending September 30, 2023 and Full Year Ending March 31, 2024 CI
Sakai Chemical Industry Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending March 31, 2024 CI
Sakai Chemical Industry Co., Ltd. Provides Dividend Guidance for the Second Quarter of Fiscal Year Ending March 31, 2024 CI
Sakai Chemical Industry Co., Ltd. announced that it has received ¥3.03513722 billion in funding from IA Partners Inc. CI
Sakai Chemical Industry Co., Ltd. announced that it expects to receive ¥3.03513722 billion in funding from IA Partners Inc. CI
Sakai Chemical Industry Co., Ltd. Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Sakai Chemical Industry Co., Ltd. Expects to Pay Dividend for the Year Ending March 31, 2023 CI
Sakai Chemical Industry Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2023 CI
Sakai Chemical Industry Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2023 CI
More news
1 day+0.55%
1 week-0.15%
Current month+4.65%
1 month+1.56%
3 months+7.55%
Current year+7.89%
More quotes
1 week
1 987.00
Extreme 1987
2 045.00
1 month
1 907.00
Extreme 1907
2 076.00
Current year
1 866.00
Extreme 1866
2 076.00
1 year
1 766.00
Extreme 1766
2 207.00
3 years
1 708.00
Extreme 1708
2 484.00
5 years
1 416.00
Extreme 1416
2 909.00
10 years
1 315.00
Extreme 1315
3 350.00
More quotes
Managers TitleAgeSince
President 64 82-03-31
Chief Administrative Officer 59 88-03-31
Chief Tech/Sci/R&D Officer 65 81-03-31
Members of the board TitleAgeSince
President 64 82-03-31
Chief Tech/Sci/R&D Officer 66 14-03-31
Director/Board Member 65 11-08-31
More insiders
Date Price Change Volume
24-04-25 2,024 +0.55% 27 800
24-04-24 2,013 -0.10% 23,300
24-04-23 2,015 -0.35% 19,200
24-04-22 2,022 +0.70% 42,300
24-04-19 2,008 -1.42% 37,800

Delayed Quote Japan Exchange, April 25, 2024 at 02:00 am EDT

More quotes
SAKAI CHEMICAL INDUSTRY CO., LTD. is a Japan-based company principally manufactures and sells chemical industry products. The Company operates in two business segments. Chemical segment is involved in the manufacture and sale of chemical products. Main products include titanium products, resin additives, barium products, catalyst products, electronic materials, zinc products, functional materials, and other chemicals such as organophosphorus compounds, organic sulfur compounds, as well as water treatment agents, among others. Medical segment is involved in the manufacture and sale of pharmaceuticals and quasi drugs. Main products include barium X-ray contrast media, medical drugs for peptic ulcer & reflux esophagitis, general drugs such as cold and gastrointestinal drugs, functional foods, as well as other products such as medical devices, among others.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
2,024 JPY
Average target price
2,500 JPY
Spread / Average Target
+23.52%
Consensus